1. Home
  2. TILE vs NEO Comparison

TILE vs NEO Comparison

Compare TILE & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Interface Inc.

TILE

Interface Inc.

N/A

Current Price

$37.42

Market Cap

2.2B

ML Signal

N/A

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

N/A

Current Price

$17.84

Market Cap

2.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TILE
NEO
Founded
1973
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Precision Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.1B
IPO Year
1994
2008

Fundamental Metrics

Financial Performance
Metric
TILE
NEO
Price
$37.42
$17.84
Analyst Decision
Buy
Strong Buy
Analyst Count
1
8
Target Price
$36.00
$13.38
AVG Volume (30 Days)
477.4K
1.7M
Earning Date
05-08-2026
04-28-2026
Dividend Yield
0.29%
N/A
EPS Growth
32.43
N/A
EPS
1.28
N/A
Revenue
$1,386,854,000.00
N/A
Revenue This Year
$6.72
$10.63
Revenue Next Year
$5.61
$9.73
P/E Ratio
$28.91
N/A
Revenue Growth
5.41
N/A
52 Week Low
$24.40
$7.07
52 Week High
$40.50
$19.76

Technical Indicators

Market Signals
Indicator
TILE
NEO
Relative Strength Index (RSI) 49.56 59.50
Support Level $27.29 $15.72
Resistance Level $40.07 N/A
Average True Range (ATR) 1.08 0.75
MACD -0.36 0.00
Stochastic Oscillator 11.91 43.94

Price Performance

Historical Comparison
TILE
NEO

About TILE Interface Inc.

Interface Inc is engaged in the design, production, and sale of carpet tiles. It also provides Luxury Vinyl tiles and rubber flooring. The company mainly targets corporate and noncorporate office markets, including government, education, healthcare, hospitality, and retailers. Its geographical segments include the Americas, Europe, and Asia-Pacific. It has two operating and reportable segments- namely Americas (AMS) and Europe, Africa, Asia and Australia (collectively EAAA). Key revenue is generated from AMS segment. Its products include: ESD, Acoustic, Extreme Wear, and Quick Installation System (nTx).

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: